Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1

被引:20
|
作者
Zakharenko, Alexandra L. [1 ]
Luzina, Olga A. [2 ]
Chepanova, Arina A. [1 ]
Dyrkheeva, Nadezhda S. [1 ]
Salakhutdinov, Nariman F. [2 ]
Lavrik, Olga I. [1 ]
机构
[1] Russian Acad Sci, Siberian Branch, Novosibirsk Inst Chem Biol & Fundamental Med, 8 Akad Lavrentieva Ave, Novosibirsk 630090, Russia
[2] Russian Acad Sci, Siberian Branch, NN Vorozhtsov Novosibirsk Inst Organ Chem, 9 Akad Lavrentieva Ave, Novosibirsk 630090, Russia
基金
俄罗斯科学基金会;
关键词
natural compound; derivative; TDP1; inhibitors; anticancer therapy; TOP1; STRAND BREAK REPAIR; TOPOISOMERASE-I; USNIC ACID; SPINOCEREBELLAR ATAXIA; BIOLOGICAL-ACTIVITY; PHOSPHOLIPASE-D; HUMAN-CELLS; TDP1; IDENTIFICATION; DAMAGE;
D O I
10.3390/ijms24065781
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an important repair enzyme that removes various covalent adducts from the 3 ' end of DNA. Particularly, covalent complexes of topoisomerase 1 (TOP1) with DNA stabilized by DNA damage or by various chemical agents are an examples of such adducts. Anticancer drugs such as the TOP1 poisons topotecan and irinotecan are responsible for the stabilization of these complexes. TDP1 neutralizes the effect of these anticancer drugs, eliminating the DNA adducts. Therefore, the inhibition of TDP1 can sensitize tumor cells to the action of TOP1 poisons. This review contains information about methods for determining the TDP1 activity, as well as describing the inhibitors of these enzyme derivatives of natural biologically active substances, such as aminoglycosides, nucleosides, polyphenolic compounds, and terpenoids. Data on the efficiency of combined inhibition of TOP1 and TDP1 in vitro and in vivo are presented.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] 5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl-DNA Phosphodiesterase I
    Sirivolu, Venkata Ramana
    Vernekar, Sanjeev Kumar V.
    Marchand, Christophe
    Naumova, Alena
    Chergui, Adel
    Renaud, Amelie
    Stephen, Andrew G.
    Chen, Feng
    Sham, Yuk Y.
    Pommier, Yves
    Wang, Zhengqiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8671 - 8684
  • [22] Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites
    Rechkunova, N. I.
    Lebedeva, N. A.
    Lavrik, O. I.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2015, 41 (05) : 474 - 480
  • [23] Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites
    N. I. Rechkunova
    N. A. Lebedeva
    O. I. Lavrik
    Russian Journal of Bioorganic Chemistry, 2015, 41 : 474 - 480
  • [24] Structure Modeling of Human Tyrosyl-DNA Phosphodiesterase 1 and Screening for Its Inhibitors
    Gushchina, I. V.
    Nilov, D. K.
    Zakharenko, A. L.
    Lavrik, O. I.
    Svedas, V. K.
    ACTA NATURAE, 2017, 9 (02): : 59 - 66
  • [25] Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
    Luzina, Olga
    Filimonov, Alexander
    Zakharenko, Alexandra
    Chepanova, Arina
    Zakharova, Olga
    Ilina, Ekaterina
    Dyrkheeva, Nadezhda
    Likhatskaya, Galina
    Salakhutdinov, Nariman
    Lavrik, Olga
    JOURNAL OF NATURAL PRODUCTS, 2020, 83 (08): : 2320 - 2329
  • [26] Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1)
    Bermingham, Alun
    Price, Edmund
    Marchand, Christophe
    Chergui, Adel
    Naumova, Alena
    Whitson, Emily L.
    Krumpe, Lauren R. H.
    Goncharova, Ekaterina I.
    Evans, Jason R.
    McKee, Tawnya C.
    Henrich, Curtis J.
    Pommier, Yves
    O'Keefe, Barry R.
    SLAS DISCOVERY, 2017, 22 (09) : 1093 - 1105
  • [27] Enhancement of the Clastogenic Effects of Topotecan In Vivo by Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
    Zhanataev, A. K.
    Kulakova, A. V.
    Luzina, O. A.
    Khomenko, T. M.
    Volcho, K. P.
    Salakhutdinov, N. F.
    Durnev, A. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 177 (01) : 30 - 34
  • [28] Selection of bifunctional tyrosyl-DNA phosphodiesterase 1 inhibitors through molecular modeling
    Gushchina, I.
    Svedas, V.
    Nilov, D.
    FEBS OPEN BIO, 2018, 8 : 455 - 455
  • [29] Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2)
    Wang, Ping
    Elsayed, Mohamed
    Plescia, Caroline
    Kiselev, Evgeny
    Marchand, Christophe
    Zeleznik, Olga
    Agama, Keli
    Pommier, Yves
    Cushman, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [30] Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2)
    Wang, Ping
    Elsayed, Mohamed S. A.
    Plescia, Caroline B.
    Ravji, Azhar
    Redon, Christophe E.
    Kiselev, Evgeny
    Marchand, Christophe
    Zeleznik, Olga
    Agama, Keli
    Pommier, Yves
    Cushman, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (08) : 3275 - 3288